ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,822 | -72.2% | 1,479 | -68.0% | 0.01% | -78.1% |
| Q2 2023 | $110,769 | +20.3% | 4,625 | -20.0% | 0.03% | +3.2% |
| Q4 2022 | $92,081 | +18.1% | 5,784 | +4.2% | 0.03% | -35.4% |
| Q2 2022 | $78,000 | -74.3% | 5,550 | -55.7% | 0.05% | -68.6% |
| Q1 2022 | $304,000 | +12.2% | 12,517 | +8.0% | 0.15% | +21.4% |
| Q4 2021 | $271,000 | +71.5% | 11,589 | +21.8% | 0.13% | +23.5% |
| Q3 2021 | $158,000 | -33.9% | 9,518 | -2.8% | 0.10% | -32.0% |
| Q2 2021 | $239,000 | +455.8% | 9,793 | +492.1% | 0.15% | +111.3% |
| Q1 2021 | $43,000 | – | 1,654 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |